Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “M0”

226 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 226 results

Large-scale testing (Phase 3)Study completedNCT00793377
What this trial is testing

Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer

Who this might be right for
Primary Breast Cancer
GBG Forschungs GmbH 913
Large-scale testing (Phase 3)Looking for participantsNCT05448547
What this trial is testing

Immediate Curative vs Conservative Treatment in Older Men With M0, High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Sven Löffeler 980
Testing effectiveness (Phase 2)Study completedNCT00489008
What this trial is testing

SRS Study in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 141
Early research (Phase 1)Ended earlyNCT00156299
What this trial is testing

Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate

Who this might be right for
Leukemia
Rutgers, The State University of New Jersey 15
Large-scale testing (Phase 3)Study completedNCT00021450
What this trial is testing

Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 819
Large-scale testing (Phase 3)UnknownNCT00091234
What this trial is testing

Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

Who this might be right for
Leukemia
European Organisation for Research and Treatment of Cancer - EORTC 279
Testing effectiveness (Phase 2)Study completedNCT04154943
What this trial is testing

Study of Cemiplimab in Patients With Type of Skin Cancer Stage II to IV Cutaneous Squamous Cell Carcinoma

Who this might be right for
Cutaneous Squamous Cell Carcinoma
Regeneron Pharmaceuticals 79
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353476
What this trial is testing

Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)Post Surgical
Shanghai Zhongshan Hospital 38
Large-scale testing (Phase 3)Study completedNCT00002945
What this trial is testing

High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Roswell Park Cancer Institute 61
Testing effectiveness (Phase 2)Study completedNCT00348595
What this trial is testing

Study of 2 Different Doses of Revlimid in Biochemically Relapse Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 77
Large-scale testing (Phase 3)Ended earlyNCT00309517
What this trial is testing

Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C

Who this might be right for
Rectal Cancer Dukes B, Dukes C
Austrian Breast & Colorectal Cancer Study Group 700
Early research (Phase 1)Ended earlyNCT03066154
What this trial is testing

Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancer

Who this might be right for
Prostatic Neoplasms
The Netherlands Cancer Institute 24
Early research (Phase 1)Study completedNCT00093483
What this trial is testing

Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Roswell Park Cancer Institute 61
Large-scale testing (Phase 3)Study completedNCT00002719
What this trial is testing

Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia

Who this might be right for
LeukemiaNeutropenia
European Organisation for Research and Treatment of Cancer - EORTC 500
Large-scale testing (Phase 3)Study completedNCT01122121
What this trial is testing

Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer

Who this might be right for
Prostatic Neoplasms, Locally Advanced
Takeda 273
Not applicableStudy completedNCT01385150
What this trial is testing

Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia

Who this might be right for
Leukemia
Eastern Cooperative Oncology Group 220
Early research (Phase 1)Ended earlyNCT03518320
What this trial is testing

Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder Cancer TNM Staging Primary Tumor (T) T2Bladder Cancer TNM Staging Primary Tumor (T) T2ABladder Cancer TNM Staging Primary Tumor (T) T2B+6 more
Taris Biomedical LLC 13
Testing effectiveness (Phase 2)Study completedNCT01620359
What this trial is testing

Study of ExAblate Focused Ultrasound Ablation of Breast Cancer

Who this might be right for
Breast Cancer
InSightec 14
Testing effectiveness (Phase 2)Ended earlyNCT00089388
What this trial is testing

Cilengitide in Treating Patients With Acute Myeloid Leukemia

Who this might be right for
Adult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+9 more
National Cancer Institute (NCI) 70
Not applicableEnded earlyNCT01821768
What this trial is testing

Axillary Ultrasound With or Without Sentinel Lymph Node Biopsy in Detecting the Spread of Breast Cancer in Patients Receiving Breast Conservation Therapy

Who this might be right for
Breast Neoplasms
Washington University School of Medicine 69
Next Page